Ventilatory control in peripheral chemoreceptor-denervated ponies during chronic hypoxemia.
The present study was designed to provide further insight into the role of the carotid and aortic chemoreceptors in ventilatory (VE) acclimatization during sojourn at altitude. Measurements were made: 1) on 10 ponies near sea level (SL, 740 Torr) under normal conditions, 2) on 6 of these at SL following chemoreceptor denervation (CD), and 3) subsequently on all 10 during 4 days of hypobaric hypoxia (PaO2 = 40-47 Torr). CD resulteo in hypoventilation at SL (deltaPaCO2 = d8 Torr, P less than 0.05), and it prevented hyperventilation normally observed with injection of NaCN and acute exposure to hypoxia (less than 1 h). In contrast, hyperventilation was evident in normal ponies during acute hypoxia (deltaPaCO2 = -6.7 Torr). Ventilation increased in both groups between the 2nd and 8th h of hypoxia (deltaPaCO2 from 1 h = -4 Torr, P less than 0.05). This change, a common characteristic of acclimatization, persisted throughout 4 days of hypoxia in the normal ponies. However, in the CD ponies this change was evident consistently only through the 12th h and after the 44 h hyperventilation was no longer evident. We conclude that the peripheral chemoreceptors are essential in ponies for normal VE acclimatization to this degree of hypoxemia. Two additional findings in CD ponies suggest the presence of a CNS inhibitory influence on the VE control center during chronic hypoxemia. First, acute hyperoxygenation on the 4th day of hypoxemia induced hyperventilation (deltaPaCO2 = -5 Torr, P less than 0.05). Second, again on the 4th day and during hyperoxygenation, VE responsiveness to CO2 and doxapram HCl was greater than at sea level.
D000064:Acclimatization; D000136:Acid-Base Equilibrium; D000531:Altitude; D000818:Animals; D001016:Aortic Bodies / Q000502:physiology* / Q000503:physiopathology; D002245:Carbon Dioxide; D002344:Carotid Body / Q000502:physiology* / Q000503:physiopathology; D002555:Cerebrospinal Fluid / Q000378:metabolism; D002628:Chemoreceptor Cells / Q000502:physiology* / Q000503:physiopathology; D004315:Doxapram / Q000494:pharmacology; D006736:Horses / Q000502:physiology; D000860:Hypoxia / Q000503:physiopathology; D010100:Oxygen; D010101:Oxygen Consumption; D010234:Paraganglia, Nonchromaffin / Q000502:physiology*; D012119:Respiration / Q000187:drug effects
D002245:Carbon Dioxide; D004315:Doxapram; D010100:Oxygen